Abstract
The therapeutic activity of Mapharsen, under the influence of BAL, has been studied in relation to its toxicity in mice infected with T. equiperdum. It was found that: 1) The curative activity of the arsenical is inhibited by much lower doses of BAL than the trypanocidal activity. 2) The therapeutic activity of the arsenical is inhibited by relatively lower doses of BAL than the toxicity, as measured by the mortality figures. 3) In general, the higher the dose of the arsenical the more BAL proportionately is required for inhibition. 4) The extremely fast decrease in the curative action of Mapharsen, when given in conjunction with BAL, precludes the possibility of this form of combined chemotherapy.
Footnotes
- Received July 14, 1947.
- 1948 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.